Peptide EncyclopediaA clinical monograph on zinc-thymulin — the zinc-dependent thymic nonapeptide marketed as a topical hair-growth peptide. One small open-label human trial, solid zinc-biomarker biology, no RCT, and an unsettled 2026 legal status.
Peptide Encyclopedia11 MIN READ
Peptide EncyclopediaA clinical monograph on Vilon — the synthetic Lys-Glu dipeptide bioregulator marketed for immune and longevity support. Rodent and in-vitro signals only, no human RCT, and no legal compounding pathway in 2026.
Peptide Encyclopedia10 MIN READ
Peptide EncyclopediaA clinical monograph on thymulin — the zinc-dependent thymic nonapeptide (facteur thymique serique). Real T-cell biology, two small 1980s rheumatoid-arthritis RCTs, otherwise preclinical, and an unsettled 2026 legal status.
Peptide Encyclopedia11 MIN READ
Peptide EncyclopediaA clinical monograph on thymosin alpha-1 (Zadaxin/thymalfasin) — an immune-calibrating thymic peptide with real human RCTs in hepatitis B, a negative phase 3 sepsis trial, and an unsettled 2026 US legal status.
Peptide Encyclopedia12 MIN READ
Peptide EncyclopediaA clinical monograph on Thymogen / oglufanide / IM-862 (Glu-Trp) — the rare bioregulator peptide tested in real human RCTs. A Grade-A negative oncology result, a Grade-B human VEGF effect, and weakly-evidenced 'immune support' claims.
Peptide Encyclopedia11 MIN READ